Hepatitis D MRI: Difference between revisions
(Category) |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
The [[MRI]] findings in patients with [[hepatic cirrhosis]] may include: a shrunken [[liver]] with nodular appearance, and signs of [[portal hypertension]], such as [[splenomegaly]] and [[ascites]]. | The [[MRI]] findings in patients with [[hepatic cirrhosis]] may include: a shrunken [[liver]] with nodular appearance, and signs of [[portal hypertension]], such as [[splenomegaly]] and [[ascites]]. | ||
==References== | ==References== | ||
Revision as of 22:37, 14 February 2018
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D MRI On the Web |
|
American Roentgen Ray Society Images of Hepatitis D MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
The MRI may be used to diagnose/monitor biliary obstruction, cirrhosis, and hepatocellular carcinoma in patients with hepatitis D. MRI findings in these patients may include: nodular appearance of the liver and signs of portal hypertension, such as ascites and splenomegaly.
MRI
In patients with hepatitis D, an MRI may be performed to:[1]
- Exclude biliary obstruction
- Diagnose/monitor hepatic cirrhosis and hepatocellular carcinoma
The MRI findings in patients with hepatic cirrhosis may include: a shrunken liver with nodular appearance, and signs of portal hypertension, such as splenomegaly and ascites.
References
- ↑ Bialecki ES, Di Bisceglie AM (2005). "Diagnosis of hepatocellular carcinoma". HPB (Oxford). 7 (1): 26–34. doi:10.1080/13651820410024049. PMC 2023919. PMID 18333158.